BiotechTube
Home/Neuren Pharmaceuticals/Dr. Juha P. Tolonen
DJ

Dr. Juha P. Tolonen

Chief Medical Officer (CMO)

Neuren Pharmaceuticals

Therapeutic Areas

Neurodevelopmental DisordersRare DiseasesNeurology

Neuren Pharmaceuticals Pipeline

DrugIndicationPhase
Trofinetide (NNZ-2566) / DAYBUE™Rett SyndromeApproved
Trofinetide (NNZ-2566)Fragile X SyndromePhase 2
NNZ-2591Phelan-McDermid SyndromePhase 2

Leadership Team at Neuren Pharmaceuticals

JP
Jon Pilcher
Chief Executive Officer (CEO)
RT
Richard Treagus
Executive Director and Company Secretary
TF
Tony Fifer
Non-Executive Chairman
AL
Andrew L. Gaines
Non-Executive Director
DS
Dr. Stephen Clarke
Non-Executive Director
DM
Dr. Michael D. Snape
Chief Development Officer (CDO) and Company Founder
View full Neuren Pharmaceuticals profile